Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
Aevis Victoria. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
Aevis Victoria's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Aevis Victoria has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Healthcare industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare Aevis Victoria's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare Aevis Victoria's earnings growth to the Germany market average as no estimate data is available.
Unable to compare Aevis Victoria's revenue growth to the Germany market average as no estimate data is available.
Unable to determine if Aevis Victoria is high growth as no earnings estimate data is available.
Unable to determine if Aevis Victoria is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
Aevis Victoria's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Mr. Dino Cauzza has been Chief Executive Officer of Swiss Medical Network at Aevis Victoria SA since May 01, 2018. Mr. Cauzza joined Swiss Medical Network in April 2017 as Delegate of the Board of its subsidiary GSMN Ticino SA, operating Clinica Sant’Anna and Clinica Ars Medica. He benefits of a long experience in the healthcare sector in Switzerland. He worked for many years at Ente Ospedaliero Cantonale (EOC), first as Chief Internal Auditor and then as Chief Financial Officer. He obtained a license in economics (lic. oec. HSG) at the University of St. Gallen and qualified as a chartered accountant. Founder of the consultancy firm Alameda SA, he is also a Board member of several companies, mainly in Ticino.
Insufficient data for Dino to compare compensation growth.
Insufficient data for Dino to establish whether their remuneration is reasonable compared to companies of similar size in Germany.
Management Team Tenure
Average tenure and age of the
management team in years:
The average tenure for the Aevis Victoria management team is less than 2 years, this suggests a new team.
Delegate of the Board
Chief Financial Officer
COO & CEO of Infracore
Chief People & Information Officer
Séverine Van der Schueren
Chief Administrative Officer
Chief Executive Officer of Swiss Medical Network
Chief Executive Officer of Victoria - Jungfrau Collection
Board of Directors Tenure
Average tenure and age of the
board of directors in years:
The tenure for the Aevis Victoria board of directors is about average.
Aevis Victoria SA provides services to healthcare, lifestyle, and infrastructure sectors in Switzerland. The company operates through Hospitals, Hospitality, Telemedicine, and Real Estate segments. It operates 17 hospitals with 1,111 beds; manages 4 luxury hotels; and owns and rents 47 healthcare and hospitality related real estate properties with a total rentable surface of 216,674 sqm. The company also provides ambulance and day clinic services. In addition, it engages in the aesthetic hospital, patient hotel, real estate management, stem cells, cosmetics, and publishing businesses, as well as organizes seminars. The company was formerly known as AEVIS Holding SA and changed its name to Aevis Victoria SA in June 2015. The company is headquartered in Fribourg, Switzerland. Aevis Victoria SA is a subsidiary of M.R.S.I. Medical Research, Services & Investments S.A.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.